PSKH2: A Promising Drug Target and Biomarker for Psychosis (G85481)

Target Name: PSKH2

NCBI ID: G85481

PSKH2

PSKH2: A Promising Drug Target and Biomarker for Psychosis

Psychosis, a mental disorder characterized by a disconnection from reality, is a significant public health issue worldwide. According to the World Health Organization (WHO), approximately 1% of the global population experiences psychosis, with approximately 50% of cases being related to the treatment of mental illness. The treatment options for psychosis are limited, and the development of new, effective drugs is essential. One promising drug target for psychosis is the serine/threonine kinase PSKH2.

PSKH2: Structure and Function

PSKH2 is a protein that is expressed in various tissues, including the brain, and plays a crucial role in the intracellular signaling pathway known as the TGF-β pathway. The TGF-β pathway is a well-established signaling pathway that is involved in the development, maintenance, and regulation of tissues, including brain. Mutations in the TGF-β pathway have been linked to various diseases, including psychosis.

PSKH2 is a key regulator of TGF-β signaling in the brain. It consists of two main isoforms, PSKH2伪 and PSKH2尾, which differ in their catalytic activity. PSKH2伪 is the catalytic subunit, while PSKH2尾 is the regulatory subunit. PSKH2伪 has been shown to play a crucial role in the regulation of neuronal excitability and the development of neurodegenerative diseases.

PSKH2尾 has also been shown to be involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Synaptic plasticity is important for the development of new neural connections and the regulation of learning and memory.

PSKH2 as a Drug Target

PSKH2 has been identified as a potential drug target for the treatment of psychosis due to its involvement in the TGF-β pathway. The TGF-β pathway is involved in the development of various psychiatric disorders, including psychosis. By targeting PSKH2, researchers hope to reduce the production of pro-inflammatory cytokines, which have been linked to the development of psychosis.

One mechanism by which PSKH2 may contribute to the development of psychosis is its role in the regulation of neuronal excitability. Studies have shown that PSKH2伪 is involved in the regulation of neurotransmitter release and the modulation of neuronal excitability. This modulation of neuronal excitability is important for the development of various psychiatric disorders, including psychosis.

Another mechanism by which PSKH2 may contribute to the development of psychosis is its role in the regulation of synaptic plasticity. As mentioned earlier, PSKH2尾 has been shown to be involved in the regulation of synaptic plasticity. This regulation is important for the development of new neural connections and the regulation of learning and memory.

PSKH2 as a Biomarker

PSKH2 has also been identified as a potential biomarker for the development of psychosis. The development of psychosis is often associated with the production of pro-inflammatory cytokines, which can cause inflammation throughout the brain. The production of these cytokines is tightly regulated by PSKH2.

Research has shown that individuals with schizophrenia, a common form of psychosis, have lower levels of PSKH2 than healthy individuals. This suggests that PSKH2 may be a potential biomarker for the development of psychosis. Furthermore, individuals with psychosis have higher levels of pro-inflammatory cytokines than healthy individuals. This suggests that PSKH2 may be involved in the regulation of the immune response and the development of psychosis.

Conclusion

PSKH2 is a protein that is involved in the intracellular signaling pathway known as the TGF-β pathway. It is a potential drug target for the treatment of psychosis due to its involvement in the regulation of TGF-β signaling and the regulation of neuronal excitability and synaptic plasticity. PSKH2 has also been identified as a potential biomarker for the development of psychosis. Further research is needed to fully understand the role of PSKH2 in the development of psychosis and to develop effective new treatments.

Protein Name: Protein Serine Kinase H2

The "PSKH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSKH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets